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Introduction 
Glaucoma is well-known as a leading cause of blindness in the United States, 
afflicting more than 2 million Americans, of which approximately one million are not 
aware that they have it. 1 Glaucoma has been classically defined as a group of ocular 
conditions characterized by progressive loss of visual field due to optic nerve damage 
and, in most cases, elevated intraocular pressure (lOP). Primary open angle glaucoma 
(POAG) is the most common presentation warranting continued research and discussion. 
Historically, glaucoma was diagnosed based on elevated lOP alone, indicating 
increased pressure as the etiology. Glaucoma was viewed as a disorder of aqueous 
humor dynamics, with the optic nerve as an ilUlocent but vulnerable bystander.2 In recent 
years, it is becoming more apparent that glaucoma is a multi-factorial condition 
characterized by progressive optic neuropathy leading to distinctive visual field loss.3 
The most common theories pertaining to optic nerve damage purported are mechanical 
compression, ischemic vascular, excitotoxicity of ganglion cells, and genetically pre-
programmed cell death (apoptosis). It is likely that a combination of mechanisms plays a 
role in optic nerve head (ONH) damage and not the result of one theory in particular. 
Elevated intraocular pressure affects the nerve in several ways. First, elevated 
lOP causes mechanical stress at the lamina cribrosa through which the ganglion cell 
axons pass. The level of lOP that produces mechanical stress in any particular optic nerve 
is dependent on the structural integrity of the lamina. Second, high lOP restricts blood 
flow to the ONH in susceptible individuals who do not have adequate compensatory 
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autoregulatory mechanisms, causing increased tissue pressure within the optic nerve and 
increased extraluminal vascular pressure.4 Decreased optic nerve perfusion may 
mechanically weaken the connective tissue matrix supporting the lamina cribrosa, 
increasing its susceptibility to damage at any level of intraocular pressure. 5 In addition, 
elevated lOP may ultimately physically block axonal transport of brain derived 
neurotrophic growth factor transported from the brain to the ganglion cells. When 
deprivation of a vital nutrient occurs, the cell loses the signal to "stay alive" and thus 
expresses the genetic potential for apoptosis (pre-programmed cell death). Apoptosis 
causes enzymes to be turned on, causing the ganglion cell to self-ingest its own DNA and 
initiate phagocytosis, leading to cellular "suicide".6 The dead cells then release excess 
glutamate into the extracellular space which binds to receptors, propagating the opening 
of calcium channels on adjacent ganglion cells. 6 From this, excess calcium floods into 
adjacent, healthy ganglion cells in a chain-reaction, causing them in tum to undergo 
apoptosis. Elevated lOP may also induce further release of glutamate intra-cellularly, 
eliciting accumulation of nitric oxide and destructive free radicals, which are toxic to 
healthy ganglion cells. Despite the interrelationship of these proposed mechanisms, this 
paper will focus on the vascular component related to glaucoma. 
The eye is one of the best-perfused organs in the body. In humans, the eye has 
two separate systems of blood vessels that differ both anatomically and physiologically: 
the retinal vessels supplying the inner two-thirds of the eye, and the rest of the eye 
supplied by the uveal or ciliary vessels. However, in order to better understand ONH 
perfusion and the relationship to glaucoma, discussion of ocular blood vessel pathways, 
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beginning with the internal carotid arteries forward to the vasculature of the eye, is 
warranted. 
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Figure 1: Orbital blood supply 
(Source: www.bartleby.com/107/lmages/ small/image514.jpg) 
The right common carotid artery originates from the bifurcation of the brachio-
cephalic trunk, while the left common carotid originates directly from the aortic arch.7 
Each common carotid artery bifurcates into an internal and external carotid artery in most 
individuals just below the angle of the jaw and approximately at the level of the thyroid 
cartilage.8 The internal carotid artery (ICA) then enters the skull through the foramen 
lacerum within the petrous portion of the temporal bone prior to reaching the cavernous 
sinus. The ICA ascends above the clinoid processes dividing into anterior and middle 
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cerebral arteries, sometimes referred to as the carotid siphon. 8 Near the supraclinoid 
process, the ICA gives off its first important branches: ophthalmic, posterior 
communicating, and anterior choroidal arteries, which usually arise in this order. 
The ophthalmic artery passes through the optic canal entering into the orbit.9 
Throughout its course, many branches emerge: the central retinal artery (CRA), ciliary 
arteries, ethmoid arteries, supraorbital artery, muscular artery, medial palpebral arteries, 
supratrochlear arteries, and dorsonasal artery.9 Discussion will be provided on the arteries 
supplying the ONH - the CRA, ciliary arteries, and pial supply. 
The CRA is the first branch to emerge from the ophthalmic artery and enters the 
dural sheath of the optic nerve approximately ten millimeters posterior to the globe. The 
CRA enters just nasal to the center of the optic nerve and gives rise to four branch retinal 
arteries, each supplying a quadrant of the retina and a portion of the anterior nerve head. 1 0 
The short posterior ciliary arteries anse as one or two branches which further 
divides into ten to twenty branches entering the sclera around the optic nerve forming an 
arterial network within the choroidal stroma, the choroidal arteries.9 Some of the 
branches anastamose to form the circle of Zinn-Haller.9 
The ONH can be divided into four gross regions from anterior to posterior: the 
superficial nerve fiber layer (NFL), prelaminar region, lamina cribrosa region, and 
retrolaminar region.4 The first two anterior portions of the ONH display similar 
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microvascular morphologies to the retina and its circulation. The vessels of the NFL and 
prelamina consist of tight junctions, capillary endothelial non-fenestrations, and a high 
number of intramural pericytes. 11 In addition, autoregulation within the ONH capillary 
beds is similar to the retinal circulation. Autoregulation is the physiologic process an 
organ (in this case the eye) uses to maintain normal blood flow in the presence of varying 
perfusion pressures. 
Figure 2: Blood supply to optic nerve 
(Source: webeye.ophth.uiowa.edu/dept/aion/figla_.jpg) 
The superficial nerve fiber layer portion is principally supplied by the CRA 
arterioles which emanate from the peripapillary vessels. The prelaminar portion receives 
its blood supply from the vessels emanating from a ring (complete or incomplete) termed 
the circle of Zinn-Haller. This ring gets its supply from branches of the short posterior 
ciliary arteries, ultimately derived from the ophthalmic artery. 12 Other minor 
contributions may be from the pial vessels emerging from the CRA and small vessels of 
the superficial nerve fiber layer. The orbital portion of the optic nerve derives its blood 
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supply from the pial circulation and perhaps also to some extent from the ophthalmic 
artery and its branches, including the central retinal artery. That portion of the optic 
nerve lying in the optic canal derives its arterial blood supply from the ophthalmic artery, 
while the intra-cranial part of the optic nerve is supplied centripetally through the pial 
vessels. The blood is drained from the ONH via the central retinal vein. 
Hemodynamics and Glaucoma 
For many years, the development of glaucomatous atrophy of the optic nerve was 
thought to be secondary to raised intraocular pressure. However, at the time of diagnosis, 
up to 30% of those with glaucoma have normal intraocular pressure. 13 This discrepancy 
points to additional mechanisms of glaucomatous damage. Several other theories have 
been proposed, as outlined in the introduction; however this paper will focus on the role 
of vascular perfusion in glaucoma. Before discussing the role of ocular hemodynamics 
in glaucoma, it is necessary to provide a background to the basic physiologic control 
mechanisms of blood flow to the retina. 
Physiology of Blood Flow in the Retina in Normals 
As previously mentioned, there are two separate blood supplies to the retina. The 
photoreceptors and retinal pigmented epithelium (RPE) cells receive their supply from 
the choroidal capillary bed, while the central retinal artery provides nutrition to the inner 
retinal layers.14 Two blood-retinal barriers are formed: one in the inner retinal supply 
between tight junctions formed by the endothelial cells of the capillaries and another in 
the choroidal supply by tight junctions between the RPE cells. 15 Varying levels of flow 
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have been found between the retinal and choroidal supplies. Retinal blood flow has been 
described to be only 5% of total ocular flow.16 Laser Doppler flowimetry has shown the 
average rate of blood flow for the entire retina to be approximately 80 ).lrnlmin. 1 7' 18 Due 
to the high macular demand for oxygen and nutrients, blood flow to the temporal retina is 
three times higher than the nasal side. No difference between the superior and inferior 
supplies has been found. 19 Blood flow through the choroidal supply has been difficult to 
accurately determine, due to the inaccessibility of the vasculature. If numerous studies 
on different species are averaged, it is estimated that the choroid receives 65-85% of total 
ocular blood flow. 20 Based on available research data, it appears that there is an 
approximately 10:1 ratio of choroidal:retinal blood flow. The features and differences of 
the choroidal and retinal supplies are listed in the following table:21 
Table 1: Salient features of the retinal and Choroidal circulations (Source: RobS, Weiter J 
Anatomy and Physiology- Retinal and Choroidal Circulation In: Yanoff: Ophthalmology, 
181 Ed. Mosby 1999. Section 8. 3.3.) 
Choroidal blood flow Total flow 800-1 OOOml/min 
Retinal blood flow Total flow 80ml/min 
Retinal regional blood flow Temporal versus nasal ratio 3:1 
Posterior pole and peripapillary 4:1 
versus remainder of retina ratio 
Superior versus inferior ratio 1:1 
Mean retinal circulation time 4-5 sec 
Retinal vasculature diameters Arteries at margin of optic nerve 110 !lill 
Veins at margin of optic nerve 150 !lffi 
Capillaries 5-6!-lm 
Choriocapillaris 20-25 ~ 
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Several factors play roles in controlling both blood supplies. Perfusion pressure 
and autoregulation play the most integral roles. Diastolic perfusion pressure (DPP), or 
systemic diastolic pressure minus intraocular pressure, is integral to controlling the rate 
of blood flow through vascular tissue. Obviously, a lower lOP facilitates entry of blood 
into the eye. This allows a lower diastolic pressure to overcome the pressure from within 
the eye. Perfusion pressure and blood flow are directly related. Accordingly, those with 
low DPP appear to be at risk for glaucomatous changes, because an increased lOP will 
more likely result in decreased ocular blood flow. The Baltimore Eye Study showed that 
patients with a DPP below 50 mm Hg were 6 times more likely to have glaucoma than 
those with a higher DPP.22 
Autoregulation, or the control of resistance to blood flow, is critical to controlling 
blood flow through the inner retinal supply. This is achieved through regulation of the 
vascular tone of the retinal vasculature.23 Autonomic control, endothelial factors, and 
metabolic factors such as oxygen and carbon dioxide all aid in determining vascular 
resistance. There are autoregulatory mechanisms that maintain normal perfusion pressure 
up to 30mmHg changes in IOP.24 It has been hypothesized that these autoregulatory 
mechanisms may be defective in glaucoma and that elevated lOP may lead to anterior 
nerve head ischemia. 25 
The choroidal blood supply is under direct nervous control. 26 Conversely, the 
retinal blood supply, specifically the central retinal artery, is only innervated up to the 
lamina cribrosa.27 However, this innervation may play an important role. During times of 
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extreme stress, sympathetic activity mcreases resulting in increased blood pressure. 
Innervation to only the extraocular portion of the central retinal artery spares the changes 
in the vascular tonus of the intraocular portion, thereby acting to protect the fragile 
capillaries inside the eye by preventing the excessive filling of intraocular vascular 
beds.28 It is unclear how or if this nervous control affects blood flow to the optic nerve 
head.29 
Oxygen and carbon dioxide both affect vascular resistance in varying degrees. 
Oxygen reduces vessel size, reducing retinal blood flow significantly. 30 Breathing pure 
oxygen for a small period of time has been found to constrict retinal vessels and reduce 
retinal blood flow by 55% to 60%.31 Carbon dioxide has the opposite effect. It acts more 
to negate oxygen's vasoconstrictive effect than as a true vasodilator; however a slight 
increase in retinal vascular diameter is observed upon addition of 7% carbon dioxide 
d . . h 1 . 32 unng m a atwn. This observation has fueled the controversial clinical technique of 
having patients breathe through a paper bag in hopes of expanding occluded retinal 
vessels enough to become un-occluded. There is questionable success with this treatment 
modality. 
The vascular endothelium plays an integral role in controlling retinal blood flow 
resistance through its action of maintaining the blood retinal barrier and its release 
vasoactive agents. The acetylcholine-nitric oxide cascade is an example of this . When 
the endothelium's muscarinic receptors are stimulated by acetylcholine, endothelial cells 
release nitric oxide, causing vasodilation and smooth muscle relaxation. 33 Without the 
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endothelium, acetylcholine will not dilate vessels. Another role of the vascular 
endothelium is to release a family of short chain polypeptides known as endothelins that 
are extremely potent vasoconstrictors.34 
As just discussed, blood flow to the retina is maintained by several different 
physiologic mechanisms. It is thought that all of these mechanisms work in concert to 
control blood flow to the retina. They are all necessary, and inaction or dysfunction of 
any one mechanism may result in an ischemic situation. 
Factors Affecting Ocular Blood Flow 
Several factors such as age, gender, hormone levels, exercise, medication, 
dehydration, and vascular disease have been found to play a role in the physiology of 
blood flow to the eye. The following table presents a summary of various factors and 
their effect on blood flow: 
Table 2: Various factors and their general effect on ocular blood flow 
FACTOR GENERAL EFFECT ON OCULAR BLOOD FLOW 
Age Reduction 
Gender Women (pre-menopausal) increased compared to men and post-menopausal women 
Women (post-menopausal) decreased compared to pre-menopausal women and age 
equivalent men 
Men decreased relative to age-matched pre-menopausal women, increased relative to 
age matched post menopausal women 
Exercise Increased 
Medication Varies- see following section on the effects of medication 
Dehydration Reduction 
Vascular Reduction 
Disease 
Sleep Reduction 
Disorders 
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It appears that age has a negative effect on blood flow to the optic nerve and 
surrounding tissue. Embleton and colleagues found that the retina, neuroretinal rim and 
lamina cribrosa all have decreased capillary blood flow with advancing age.35 
Furthermore, it has been found that the velocity of flow surrounding the optic nerve head 
decreases more nasally than temporally.36 Further evidence suggests that both the 
choroidal supply and the central retina artery supply decrease with advancing age.37'38 
The cause of this age-related reduction in blood flow is unclear; however several 
mechanisms have been proposed. It appears that aging results in an impaired ability of 
relaxation in the endothelium lining the capillaries.39 Increased attenuation of the 
choroid's arterioles has been observed as one of the aging changes on histological 
slides.40 This, along with a decreased number of choroidal arterioles with aging, as seen 
on indocyanine green angiography, results in a decreased choroidal blood volume.41 
Also, blood flow may be adversely affected by decreasing lumen diameter due to age-
related atherosclerotic changes.42 
Gender plays a key role in ocular hemodynamics. Pre-menopausal women show 
a significant increase in blood flow compared to age-equivalent men. However, this 
changes after menopause. Post-menopausal women show a decrease in blood flow 
relative to age-equivalent men and pre-menopausal women.43 This may be due in part to 
increased resistance in the posterior ciliary arteries as well as reduced levels of estrogen. 
It is thought that estrogen is protective in coronary heart disease and glaucomatous 
changes in pregnant women. At present, the effects of hormone replacement, specifically 
estrogen, on ocular hemodynamics have yet to be studied; however the underlying 
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mechanism that estrogen plays in prevention of cardiovascular disease is thought to be 
similar to its role in enhancing ocular blood flow. Unlike women, men don't appear to 
undergo any significant blood flow transformations other than normal aging changes.44 
Dehydration can affect vascular blood flow and resistance, which could play a 
role in blood flow to the optic nerve. Dehydration increases blood viscosity, and unless 
compensated by vessel dilation, it could potentially slow the flow rate of blood through 
both the arterial and venous circulation. It appears that mild dehydration reduces the 
peak velocity and affects resistance levels in the ophthalmic artery. In the central retinal 
artery, dehydration appears to slow the peak velocity but does not affect the resistance 
index.45 
Sleep disorders also seem to play a role in glaucomatous changes, especially in 
nonnotensive glaucoma (NTG). The mechanism for NTG remains unknown; however it 
has been widely proposed that reduced ocular blood flow caused by vasospasm or 
systemic hypotension plays an integral role in the pathogenesis ofNTG. Sleep disorders, 
such as sleep apnea, result in significant nocturnal hypoxia and increased vascular 
resistance. This may compromise the blood flow to the optic nerve head region.46 
Ocular Blood Flow in Glaucoma 
Understanding how vascular changes affect those with glaucoma has been a 
difficult process. Many individuals with glaucoma also have other vascular diseases. 
Cardiac disease, systemic hypertension and hypotension, atherosclerosis, diabetes 
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mellitus and cerebrovascular disease are the more common diseases that may be 
associated with glaucoma and can also influence ocular blood flow. 47 Unfortunately, no 
universal standard in measurement of ocular hemodynamics has been established at this 
time. Many techniques have been employed and standardization of conclusions has been 
difficult. Possibly, the underlying problem is the difficulty in imaging the orbital vessels, 
namely the ophthalmic, central retinal, and short ciliary arteries.48 Regardless, it is the 
intent of the following sections to present a comprehensive view of ocular hemodynamics 
as it relates to glaucoma. 
Autoregulation 
Blood flow is affected by glaucoma and ocular hypertension. By using flow-
associated parameters, Duijm et al.49 found that there were differences in both choroidal 
and retinal circulation in those with glaucoma versus normal subjects. Also, the type of 
glaucoma also affected blood flow. The primary open angle glaucoma (POAG) group 
showed especially slowed retinal circulation, whereas the NTG group showed delayed 
choroidal circulation. Glaucoma vascular hemodynamics are delayed when compared to 
normal patients and the type of glaucoma impacts the type of delay. 50 Since the retinal 
circulation is under autoregulation control, there are indications that in POAG, 
autoregulation is impaired because of possible mechanical damage from a chronic 
increase in intraocular pressure.51 The breakdown of autoregulation may also play a 
critical role in NTG. 
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Control of metabolites, such as endothelins and nitric oxide, to influence vessel 
diameter (resistance to flow), is the key mechanism of autoregulation control. It has been 
suggested that dysfunction in regulation of endothelins may be one of the mechanisms 
contributing to the vascular component of glaucoma. Endothelins are a class of vasa-
active peptides that appear to have an autoregulatory role in the eye. At the ciliary body, 
they act to decrease lOP by decreasing aqueous production and increasing outflow 
facility. In contrast to their beneficial role at the ciliary body, endothelins appear to have 
a damaging effect to the retinal ganglion cells (RGC) at the level of the optic nerve head. 
The following diagram illustrates presents their dual role within the eye, illustrating their 
lOP lowering effects in the anterior chamber, and their damaging processes at the optic 
nerve head: 52 
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Figure 3: The autoregulatory role of endothelin-1 (ET-1) on retinal ganglion cell (RGC) 
death leading to glaucoma and other neuropathies. lOP - intraocular pressure; RPE/ONA 
- retinal prigmcnted epithelium/optic nerve arteries; NPE = non-pigmented epithelium 
(Source: Krishnamoorthy R, Prasanna G, Yorio T. Endothelin: Is It a Contributer to 
Glaucoma Pathophysiology? Journal of Glaucoma 2002, 11(3): 259-270.) 
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Abnormally high systemic levels of endothelin-1 (ET -1) were found in normal 
tension glaucoma, where ET -1 has been found to reduce blood flow to the posterior 
ciliary arteries supplying the optic nerve. 53•54 Interestingly, ET -1 may also play a role in 
POAG. Compared to non-glaucomatous individuals, those with POAG were found to 
have abnormally high levels of ET -1.55 
Nitric oxide has several roles within the eye. It acts to influence blood flow, 
sodium transport, TOP, and neuronal viability by acting as a vasodilator, vasorelaxant and 
neurotransmitter. 56 Nitric oxide appears to play a strong role in the pathophysiology of 
glaucomatous optic neuropathy. Specifically, excessive amounts of nitric oxide react 
with free radicals to form toxic compounds (called peroxynitrites and hydroxyl radicals) 
that bind to neuronal organelles. Ultimately, this binding results in destruction and 
subsequent loss of structure and function of the retinal ganglion cells.57 Excessive 
amounts of nitric oxide appear to result from two factors. First, elevated lOP has been 
linked to the overproduction of nitric oxide. Second, elevated levels of the endothelins 
appear to result in increased levels of nitric oxide synthase 2 and nitric oxide 
concentrations in ocular tissues. 58 
A second key autoregulatory mechanism is known as myogemc regulation. 
Arteriolar blood vessels respond to increased intralumenar pressure by contracting. Thus, 
by decreasing flow this process (myogenic regulation) allows blood circulation to remain 
normal in the presence of increased perfusion pressure. 59 This mechanism tends to act 
when blood flow is above normal; however the mechanism of this control within the eye 
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is unknown and additional work is required to discover its role in glaucoma. 60 It is 
thought that choroidal flow, versus retinal flow, is more affected by myogenic processes 
than metabolite processes.61 
Vasospasm 
The apparent link between NTG and vasospasm is evident through the association 
of NTG with migraine headache62 and excessive peripheral vasoconstriction to cold.63 It 
is thought that NTG is primarily a vascular disease, this assumption suggests that 
vasospasm results in decreased blood flow to the optic nerve. Specifically, vasospasm 
results in poor perfusion, ischemia, and ganglion cell death.64 Defective autoregulatory 
mechanisms may be the underlying cause of a vasospastic event. The link between 
vasospasm and autoregulation may be to due endothelial cell dysfunction, which could be 
attributed to an imbalance between the levels of nitric oxide and ET -1. 65 Several vascular 
conditions, such as Raynaud's Syndrome,66 recurring migraine headache,67 and variant 
angina,68 have been found to be associated with increased plasma levels of ET-1. In 
addition, as previously mentioned, those with NTG also have elevated systemic levels of 
ET-1. Interestingly, they also have decreased ET-1 response to postural changes. The 
vasospastic phenomenon is more readily understood and accepted in the NTG group, 
however, it may play a role in POAG as well. Vasospasm may happen as frequently in 
the POAG group as the NTG group. In POAG patients, there appears to be a direct 
positive relationship between the level of vasoconstriction (or elevation of lOP) and the 
amount of neurotrophic damage.69 Vasospasm may also play a key role in decreasing 
choroidal flow. In normals, it appears that choroidal blood flow is independent of 
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perfusion pressure. However, those with NTG often have peripheral vasospasm and 
blood flow isn't maintained with varying perfusion pressures?0 Along with the inability 
to maintain blood flow through varying perfusion pressures, those with NTG may have 
elevated basal resistance levels that contribute to reduced blood flow. 71 •72 
NTG and Reduced Ocular Blood Flow 
Along with vasospasm, NTG patients typically present other interesting findings 
that may provide clues into how ocular perfusion and glaucoma are related. Events of 
nocturnal hypotension (reduced blood pressure during sleep) may be related to 
progression of the neuropathy and those with NTG have been found to have more 
frequent episodes of nocturnal hypotension than normals.73 Also, those with progressive 
glaucoma show significant variances in nocturnal hypotension. Another interesting 
phenomenon is the link between vasospasm and cold temperatures. In those with NTG, it 
has been shown in one study that immersion of one hand in cold water leads to worsening 
of the visual field in some patients.74 
Another sign that NTG has a vascular component is the prevalence of Drance 
hemorrhage (also known as a splinter hemorrhage), typically presenting on the inferior 
temporal rim of the nerve head. These characteristic hemorrhages in NTG appear to be 
more common than in POAG. Varying percentages of frequency of this hemorrhage in 
NTG have been reported. One study reports the frequency to be as high as 43%.75 The 
Blue Mountain Eye Study found that hemorrhage was three times more likely in NTG 
than POAG.76 The exact cause of hemorrhage is unknown, but different theories have 
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been proposed. It is unclear if the hemorrhages represent glaucoma damage, or if the 
damage present in glaucoma causes the hemorrhage. One theory purports that 
mechanical damage at the lamina cribrosa causes microvascular damage. Another theory 
argues that the hemorrhages occur as a result from a microvascular event such as 
vasospasm?7 POAG is thought to limit the amount of visible hemorrhage because the 
elevated lOP limits the amount of fluid leaving the vessel. 
Figure 4: Drance hemorrhage at the inferior temporal rim 
(Source: http://www .opt.pacificu.edu/ce/catalog/Glaucoma_Kirstein/ 
KirstGiauc.html) 
Recent advances in technology have allowed specific measurements to be made 
showing that NTG does involve reduced blood flow. A recent study using the Heidelberg 
retinal flowmetry (HRF) technology found that those with NTG have reduced blood flow 
in the peripapillary retina.78 A further indication of blood flow in those with NTG is 
reduced pulsatile blood flow (POBF). POBF is a derived measurement of ocular blood 
flow to the eye based on continuous recording of the change of intraocular pressure as the 
ocular volume of blood changes. POBF has been found to be decreased in both NTG 
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and POAG.79 Specifically, Ravalico et al found that mean POBF was 32.32% lower in 
NTG patients than normals. This deficit was found to be lower when the patients with 
NTG were in a supine position. 80 This correlates with previous information about the 
increase of nocturnal hypotension in NTG. 
Ocular Blood Flow Measurement 
Various techniques have been implemented in imaging and measuring the ocular 
blood circulation. New technologies, such as the scanning laser ophthalmoscope and 
confocal scanning laser Doppler flowmetry offer exciting possibilities, while traditional 
methods, such as fluorescein and indocyanine green angiography, still provide valuable 
information. 
Angiography 
Angiography has been the traditional method of imaging and measuring blood 
flow. It provides information about the retinal, choroidal, and optic nerve circulation. 
Two types of angiography exist: fluorescein angiography and indocyanine green 
angiography. Both types of angiography are semi-quantitative and semi-invasive in 
nature. 
Fluorescein angiography is used to visualize retinal vasculature and can be used 
to calculate capillary blood velocity by observing distance of movement of dye through 
individual capillaries in relation to time. 81 
Figure 5: Topcon retinal camera and sample fluorescein angiography. 
(Source: http://www.topcon.co.jp/iyou/iyou_e_ima2000.html) 
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Figure 6: Peak fluorescence approximately 25 seconds after fluorescein injection. Both 
arterial and venous circulations are shown in detail. (Source: Guyer D, Mandava N, 
Yannuzzi. Ancillary Tests- Fluorescein Angiography In: Yanoff: Ophthalmology, 151 Ed. 
Mosby 1999. Section 8. 8.1.) 
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The following defects have been found with angiography in glaucomatous 
patients: filling defects in the superficial optic nerve and choroid, delayed retinal artery 
and venous filling times, prolonged arteriovenous passage time and reduced velocity in 
h . l . 1 . 82 83 t e retma c1rcu at10n. ' 
Indocyanine green angiography is used to image the choroidal vasculature, 
specifically cases of choroidal neovascularization (CNV). lndocyanine green, unlike 
fluorescein, which fluoresces under visible light, is viewable only under infrared light. It 
is primarily used in those .with macular degeneration or other causes of occult CNV. 84 
The drawbacks of both angiography techniques are their semi-invasive nature and lack of 
absolute flow measurement. 
Both techniques have traditionally utilized photography and video to allow 
interpretation. Recent introduction of the scanning laser ophthalmascope (SLO) has 
increased the capabilities of angiography. The SLO operates on the principle of confocal 
light. Light is reflected off of the area of interest, and passes through an aperture before 
reaching the solid-state detector. This detector determines the voltage level, based on the 
energy level of the incoming light. The voltage level is measured in real time, and is 
used to create a video signal. This video signal is similar to those obtained with 
traditional video angiography, however, since scattered light and light from sources 
outside the focal plane cannot enter the aperture, the resolution and contrast of the image 
is improved.85 The SLO offers better penetration of corneal and lens opacities. It also 
allows for decreased retinal illumination and improved contrast since the laser beam 
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illuminates only a single spot at time.86 As with traditional angiographic techniques, SLO 
is invasive and data analysis is time consuming.87 
Color Doppler Imaging 
Instruments that utilize the Doppler effect can measure blood-flow velocities in 
the major ocular vessels. Light waves undergo a Doppler shift when they are reflected 
off moving objects, such as red blood cells. This shift is proportional to the velocity of 
the moving object. This data is then analyzed and superimposed, in color, on a standard 
image and is termed color Doppler imaging (CDI). 88 CDI is used to image the ophthalmic 
artery, the central retinal artery, and the short posterior ciliary artery.89 CDI is limited to 
determining blood-flow velocities. In order to calculate absolute volume flow, vessel 
diameter is needed, and at present, there is no feasible means of determining retrobulbar 
vessel diameter.9° CDI has been used to show reduced velocity and increased resistance 
to flow in both POAG and NTG91 • 92 , and eyes having lower velocities have more damage 
than eyes with high velocities.93'94 CDI is also limited because it can not image the short 
posterior ciliary arteries because of their lack of size and the resolution limit of CDC5 
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Figure 7: Color Doppler Imaging of the ophthalmic artery. The peak systolic velocity is 
indicated by the sharp rise. The end diastolic velocity is indicated by the gradual tail-off 
of each pulse wave. (Source: Harris A, O'Brien C. Optic Nerve Blood Flow 
Measurement. In: Yanoff: Ophthalmology, 1'1 Ed. Mosby 1999. Section 12. 9.1.) 
Confocal Scanning Laser Doppler Flowmetry 
The Heidelberg Retinal Flowmeter (HRF) combines a confocal scanning laser 
with a laser Doppler flowmeter. The scanning system of the HRF maps a retinal area of 
10 degrees by 2.5 degrees. This area is initially scanned with a resolution of 256 points 
by 64 lines. It is then scanned another 128 times to create an intensity matrix.96 Each 
point within this matrix is then assigned a power spectrum based on fast Fourier 
transformation to extract the Doppler frequency shift of the reflected light. This analysis 
is completed on each of the approximately 16,000 points within the imaged area, 
allowing for a two-dimensional map of retinal perfusion for each 10 degree by 2.5 degree 
area.97 This technology allows the HRF to obtain measurements of flow, volume and 
velocity. In glaucoma, laser Doppler flowmetry has shown reduced blood-flow velocities 
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in the lamina cribrosa and in the nasal and temporal neural rim and retina.98 The HRF has 
also shown that NTG patients present with significantly lower blood flow than age-
matched norms.99 The HRF is limited in the current expense of the instrument. Also, 
image acquisition requires 2 seconds, which requires reasonably good vision (20/40 or 
better) for stable fixation. 10° Finally, the accuracy of the HRF has been shown to have 
coefficients of reliability close to 0.85 for acute measurements of volume, velocity and 
flow. This value decreases when measured over a four-week period. To overcome this 
limitation, the Glaucoma Research and Diagnostic Center of Indiana University has 
developed a pixel-by-pixel analysis method that overcomes some of the short-falls of the 
10 by 10 pixel area method traditionally used and reduces the coefficient of variability to 
15% for increased accuracy and repeatability over longer periods of time. 101 
Figure 8: Heidelberg Retinal Flowmeter 
(Source: http://www .heidel bergcngineering.comlhrtf/hrf.html) 
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Figure 9: HRF perfusion maps. Shown from top to bottom are the reflectance map, 
volume map, flow map, and velocity map. 
(Source: http://www.heidelbergengineering.com/tutlhrf/hrf-tutorial.html) 
Ocular Blood Flow Analyzer 
Another means of determining ocular blood flow is to measure the pulsatile ocular 
blood flow (POBF). POBF is believed to be a measurement of choroidal flow. 102• 103• 104 
Dicon's Ocular Blood Flow Analyzer does this by measuring lOP 200 times continuously 
throughout the cardiac cycle. In other words, the POBF tracks changes in lOP at a 
frequency of 200 Hz. lOP rises with the systole and falls with diastole. The change in 
lOP is termed the pulse amplitude. From the measured pulse amplitude, the Ocular 
Blood Flow Analyzer' s software calculates the ocular blood flow by essentially 
measuring the entire orbital pulse. 105 Along with previously mentioned POBF deficits in 
NTG, the Ocular Blood Flow Analyzer has shown reduced pulse amplitude and POBF in 
POAG and NTG. 106 Despite its ease of use, the Ocular Blood Flow Analyzer's calculated 
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ocular blood flow is not a direct measurement of blood flow. Rather, it is a mathematic 
estimate based on several assumptions, including scleral rigidity and a model of the 
cardiac cycle. Therefore, POBF measurements are influenced by individual differences 
in scleral rigidity, ocular volume, heart rate, systemic blood pressure, and IOP. 107 
Figure 10: Paradigm's Dicon Ocular Blood Flow Analyzer 
(Source: http://www.paradigm-medical.com/pages/eq_bfa.html) 
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Figure 11: lOP variation over time via Ocular Blood Flow Analyzer pneumotonometry 
(Source: http://www.opt.pacificu.edu/ce/catalog/Giaucoma_Kirstein/KirstGiauc.html.) 
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Figure 12: Distribution of POBF in normals and glaucomatous patients 
(Source: http://www.opt.pacificu.edu/ce/catalog/Glaucoma_Kirstein/KirstGlauc.html) 
Topical Medications and Blood Flow 
The role of hemodynamics in glaucoma has sparked considerable interest 
regarding the impact of topical medications on blood flow. Of particular promise is the 
possibility of tailoring topical therapy to those with identified vascular insufficiency. 
Carbonic Anhydrase Inhibitors 
The carbonic anhydrase inhibitors (CAl) appear to favorably affect ocular 
hemodynamics in virtually all vascular beds of the posterior segment. 108 CAl's act to 
lower lOP by decreasing aqueous production, inhibiting the inter-conversion of 
bicarbonate and carbon dioxide. In the ciliary body, carbonic anhydrase acts in the 
production of bicarbonate ions, which creates the osmotic gradient necessary for aqueous 
d . 109 pro uct10n. 
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Using SLO angiography, it was shown that 2% dorzolamide significantly 
improved arteriovenous passage time of fluorescein in the retina.110 Other studies, using 
POBF, HRF and CDI, have shown an increase in ocular hemodynamics after using 
dorzolamide. 111• 112' 113 CAl's enhancement of ocular blood flow is due to their ability to 
act as a vasodilator by inhibiting the vasoconstrictive effects of endothelin-1. 114· 115 
Another remarkable finding was the improvement in visual function following 
administration of topical CAl. Contrast sensitivity and visual field perimetry both 
showed significant improvement following administration of dorzolamide. 116· 117 Trusopt, 
which is dorzolamide 2%, and Cosopt, which is a fixed combination of dorzolamide 2%-
timolol 0.5%, are two forms of topical dorzolamide manufactured by Merck & Co. 
Figure 13: Trusopt ( dorzolamide 2%) on left, and Cosopt ( dorzolamide 2%-
timolol 0.5%) on right (Source: http://www .revoptom.corn!ps/Trusopt.htm and 
http://www .cosopt. corn/ophthalmic/cosopt/hcp/index.j sp ?US _healthcare=yes) 
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Prostaglandin Analogues 
The effects of prostaglandin analogues on ocular hemodynamics have been 
favorable, but only for choroidal blood flow. Latanoprost (Xalatan) was the first 
prostaglandin analogue introduced to the ophthalmic market. It works to lower lOP by 
enhancing uveoscleral aqueous outflow. POBF measurement has shown an increase in 
choroidal flow after administration of Xalatan in normal, NTG and POAG eyes. 118• 119• 120• 
121 While acting on choroidal flow as measured by POBF, Xalatan appears to have no 
effect on retrobulbar hemodynamics as viewed by CDI. 122 The only other prostaglandin 
analogue/docosanoid studied thus far, unoprostone (Rescula), has also been shown to 
have a favorable effect on ocular blood flow by decreasing vascular resistance. 123 
Unfortunately, unlike the CAl's, the prostaglandin analogues do not appear to improve 
. . . 124 
contrast sensitiVIty. 
Figure 14: Xalatan (latanoprost 0.005%) 
(Source: http://www.bartletteye.com/xalatan.jpg) 
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Beta Blockers 
Non-selective topical beta blockers have the theoretical possibility of decreasing 
ocular blood flow by increasing vascular resistance. Increased vascular resistance is 
likely due to their sympathetic action to cause vasoconstriction via beta receptor 
blockade. 125 Beta receptors have been shown to exist in the human choroid, anterior optic 
nerve, optic nerve head and retina. 126• 127• 128 However, thus far the research has not been 
conclusive on their effect on ocular hemodynamics. Beta blockers work to reduce lOP 
by reducing aqueous production. 
Some evidence has shown that timolol (generic, Timoptic, Timoptic XE), a non-
selective beta blocker, actually acts to increase blood flow in those with POAG by 
reducing flow resistance in the short posterior ciliary arteries. 129 Another study on 
POAG patients, using the HRF, showed increased blood flow to the ONH following 
administration of timolol after 4 weeks. 130 Other studies, using laser Doppler flowmetry 
and CDI, have also shown increased blood flow following timolol administration. 131 • 132• 
133 In contrast, several studies have shown a decrease in ocular blood flow following the 
use of timolol. Carenini and associates found a significant decrease in POBF in timolol 
treated patients. 134 This result was confirmed in other studies of normals and those with 
POAG. 135• 136 Further complicating evidence comes from research that indicates timolol 
may have no effect on ocular blood flow. 137• 138• 139• 140 
While the results of timolol on blood flow are somewhat inconclusive, betaxalol 
(Betoptic-S) appears to have a favorable impact on blood flow. Betaxalol, unlike timolol, 
is a beta-1 selective blocker. In those with NTG, it has been shown to increase 
35 
retrobulbar blood flow. 141 ' 142 Whereas timolol was shown to possibly decrease choroidal 
flow, POBF remained stable in those treated with betaxolol. 143• 144 
Ate. 
Figure 15: Beta blocker examples (from left to right):Timoptic, Timoptic-XE, Betoptic S. 
(Source: http://www.revoptom.com/drugguide.asp?show=view&articleid=3) 
Alpha Agonists 
Alpha agonists are a group of drugs with potential vasoactive effects. These 
drugs, specifically brimonidine tartrate (generic, Alphagan-P), alter lOP by suppression 
of aqueous humor production and uveoscleral outflow and may exhibit a neuroprotective 
effect. 
The classic alpha agonist is apraclonidine (Iopidine ). There has been no data to 
support that either apraclonidine, or the newer alpha agonist brimonidine (Alphagan P), 
significantly alters ocular blood flow. Using CDI, it was shown that brimonidine did not 
alter the hemodynamics of the retina. 145 Another study conducted by Jonescu-Cuypers 
and associates examined the effect of brimonidine using CDI and SLO, and found no 
changes in either retrobulbar or retinal perfusion. 146 Two other studies confirm previous 
results: alpha agonists appear to have no effect on ocular blood flow.147' 148 The literature 
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demonstrates a non-existent effect which may be attributed to the minimal penetration of 
this class of drug into the posterior pole, the absence of alpha-2 adrenergic receptors in 
the posterior ciliary arteries, or the release of endothelial-derived relaxing factors .144 
Figure 16: Alphagan P 
(Source: http://www.revoptom.com/drugguide.asp?show=view&articleid=3) 
Non-topical Drugs 
From a clinical standpoint, the eye care practitioner should maintain awareness of 
the effect of systemic medications on ocular health. Steroids such as prednisolone have 
been known to cause elevated intraocular pressure in a select percentage of individuals; 
however the exact mechanism of this is unclear. The effect of beta blockers, of which the 
orally-ingested form is typically used for the treatment of systemic vascular problems, 
may or may not have ocular vascular sequelae, as mentioned prior. 
A group of drugs showing important impact on blood flow are the calcium 
channel blockers, which were initially used for angina pectoris patients. 149 By interfering 
with calcium intracellular uptake and release, they also affect blood vessels. Studies on 
animals have proven to show benefit regarding ONH and retinal blood flow 150•151 
Although visual field function stability has not been shown with these drugs on all types 
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of glaucoma, calcium-channel blockers are eventually helpful in low tension glaucoma 
patients. 15° Few studies have shown that topically applied calcium channel blockers 
improve consistency of lowering lOP than systemically administered ones. Topically 
applied calcium channel blockers are a rarity. Systemically administered calcium 
channel blockers have shown positive vascular effects on the CRA and ONH. 152' 153 
Conclusion 
Traditionally, it has been accepted that medicinal therapy for glaucoma should be 
initiated when repeatable visual field loss appears or several risk factors in addition to 
obvious ONH changes occur. However, detecting and managing glaucoma prior to 
obvious nerve or visual field changes is paramount. Pulsatile ocular blood flow analysis, 
along with other various tools for analysis, now allow clinicians to more fully understand 
an individual's risk for developing glaucoma. The goal of current glaucoma management 
is to catch and treat glaucoma as early as possible without first waiting for damage to 
occur. 
Ocular hemodynamics is a relatively new field of study regarding glaucoma and 
its progression. Clinical observations and studies show that various vascular factors may 
influence the pathogenesis of glaucomatous damage, either through reduced blood flow 
to the optic nerve head, or by malfunction in ocular autoregulation. Future research is 
needed to provide more concrete answers to the role vascular insufficiency plays in 
glaucoma. New research will also provide a more rational approach to the use of topical 
and systemic medications in the treatment of glaucoma. 
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